"Innovators" relieved, Generics companies frustrated as government drops generic substitution plans for England
This article was originally published in Scrip
The new UK coalition government has dropped plans to introduce automatic generic substitution in England because of uncertainty over whether the government's proposals would have provided real benefit to the National Health Service (NHS), says the Department of Health (DoH). Some parts of the pharmaceutical industry appeared to be relieved, but generics producers were frustrated.
You may also be interested in...
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.